Trial Profile
A study to investigate the efficacy of febuxostat, in patients with chronic severe gouty disease.
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 27 Jul 2015
Price :
$35
*
At a glance
- Drugs Febuxostat (Primary)
- Indications Gout
- Focus Therapeutic Use
- 27 Jul 2015 New trial record
- 13 Jun 2015 Trial design presented at the 16th Annual Congress of the European League Against Rheumatism.